GlaxoSmithKline (GSK) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GlaxoSmithKline (GSK plc) has issued a report detailing a recent transaction under the company’s 2015 Share Value Plan involving the award of Ordinary Shares. Senior Vice President & Company Secretary, Victoria Whyte, has been awarded 10,050 shares at a price of £16.3900 each on September 5, 2024. The announcement was formally signed by Whyte, confirming the transaction’s completion as per regulatory requirements.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.